Methylone not checked
Transcend Therapeutics · TSND-201
FollowEvery change as it happens, and a Monday email
Trials
3 active
7 in total · 2 in the EU
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “TSND-201 capsules, given orally, once a week for four consecutive weeks”In the company’s words, NCT07456696 on ClinicalTrials.gov
- Tested for
- Post Traumatic Stress Disorder (3 trials)
- Main trialPhase 3
- “This study is evaluating the safety and efficacy of TSND-201 in adults with PTSD. Eligible participants will enter a 4-week Treatment Period where they will be randomized 1:1:1 to receive one of two doses of TSND-201 or placebo, once per week. Following the Treatment Period, participants will enter an 8-week Follow-up Period.”In the company’s words, NCT07456696 on ClinicalTrials.gov
- Other names
- TSND-201
Other drugs for Post Traumatic Stress Disorder
- PsilocybinCOMPASS Pathways · Phase 2/3
- Inhaled isofluraneSedana Medical · Phase 3
- MDMARemedy · Phase 2
- HB-1HB BioTech, LLC · Phase 2
Coming up3
- Dec 2027Phase 3 trial completes · ClinicalTrials.gov
- Feb 2028Phase 3 trial completes · ClinicalTrials.gov
- Dec 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Dec 2027 | An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) | |
| Phase 3Recruiting | Feb 2028 | An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD | |
| Phase 3Enrolling by invitation | Dec 2028 | An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD | |
| Phase 2Completed | 23 Sep 2025 | An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD | |
| Phase 2Completed | 6 Oct 2025 | An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD | |
| Phase 1/2Completed | 19 Feb 2025 | A Study to Assess the Use of Methylone in the Treatment of PTSD | |
| Phase 1Completed | 13 Jul 2025 | A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026